In 2026, several clinical studies evaluated the use of artificial intelligence in breast cancer screening, going beyond retrospective tests alone. The MASAI randomized trial reported fewer cancers detected between two screening campaigns, while…
Launched by Google DeepMind on September 8, 2026, AlphaGenome Atlas provides predictions on the molecular effects of nine billion possible single-letter substitutions in the human genome. It is not…
For a long time, the idea of directly converting a thought into text belonged to the realm of science fiction. Brain-machine interfaces were limited to specialized laboratories or relied on brain implants that required surgery….